Xcout Intel
Centrexion Therapeutics Corp
Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel non-opioid therapeutics for the treatment of chronic pain and painful conditions.
Subscribe to see Centrexion Therapeutics Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Centrexion Therapeutics Corp at a glance
Centrexion Therapeutics Corp is a biotechnology company headquartered in United States. Its most recent funding round, Venture Round, raised $3.3M in November 2023. Xcout tracks 12 named people at Centrexion Therapeutics Corp, including Jeffrey B Kindler (Chief Executive Officer).
Centrexion Therapeutics Corp leadership
- Jeffrey B KindlerChief Executive Officer
- James N. Campbell, M.D.President, Chief Scientific Officer
- Mike WardChief Financial Officer/Chief Operations Officer
- Charles Oh, M.D.Chief Medical Officer
- Jonathan GuerrieroChief Development Operations Officer
- Randall Stevens, M.D.Chief Medical Strategist
6 more named people on record for Centrexion Therapeutics Corp, with roles, board committees and tenure — see the full roster →
Centrexion Therapeutics Corp funding rounds
The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Venture Round | $3.3M | 2 named | |
| SEC Form D filing | $10.3M | — | |
| SEC Form D filing | $23.8M | — | |
| SEC Form D filing | $13.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Centrexion Therapeutics Corp competitors
A few of Centrexion Therapeutics Corp's closest competitors — see the full list of competitors and alternatives →
Semnur Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, non-opioid products for pain management.
Bexson Biomedical is a US-based biopharmaceutical company situated in Santa Barbara, California, focused on the research and development of non-opioid therapeutics and drug delivery systems.
Nocion Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Watertown, Massachusetts, focused on developing novel therapeutics to treat chronic cough and other conditions.
Daya CNS, LLC is a preclinical biopharmaceutical company that develops a proprietary non-opioid pyridoindole platform for the treatment of chronic pain, substance abuse disorders, and neuropsychiatric conditions. Its product pipeline includes small molecule medications such as DDD-028 for neuropathic and inflammatory pain, DDD-024 for addiction, and DDD-016 for neuropsychiatric disorders, serving patients with unmet medical needs in neurology and addiction medicine.
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.
Exxel Pharma is a biopharmaceutical company developing small molecule therapeutics to treat neuronal hypersensitivity disorders, such as refractory chronic cough, neuropathic pain, migraine, and hyperactive bladder. The company utilizes a differentiated approach by selectively inhibiting FAAH peripherally to target first-order sensory neurons while avoiding central nervous system side effects.
Get Centrexion Therapeutics Corp's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Centrexion Therapeutics Corp in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 9 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access